-
2020/02/13
Consolidated Financial Statements for the Third Quarter Ended December 31, 2019 FY2020 (April 1, 2019 - March 31, 2020)[UNAUDITED]
（625KB）
-
2020/01/21
Takara Bio Launches a New Facility for the Research and Manufacturing of Regenerative Medicine Products
-
2020/01/16
Takara Bio and Tmunity Enter into License Agreement to Advance siRNA Technology to Improve T cell Therapies
-
2019/11/21
We have posted "financial results presentation".
（551KB）
-
2019/11/12
Consolidated Financial Statements for the Second Quarter Ended September 30, 2019 FY2020 (April 1, 2019 - March 31, 2020)[UNAUDITED]
（626KB）